GLUE
Monte Rosa Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Markus Warmuth
IPO Date
2021-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Monte Rosa Therapeutics, Inc.
CEO
Markus Warmuth
IPO Date
2021-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 11,845 |
| $20.22 |
| 25 Jun 2026 | Janku Filip | Chief Medical Officer | M-Exempt | Acquired | 30,000 | $7.56 |
| 25 Jun 2026 | Janku Filip | Chief Medical Officer | S-Sale | Disposed | 30,000 | $21.42 |
| 25 Jun 2026 | Janku Filip | Chief Medical Officer | M-Exempt | Disposed | 6,000 | $7.56 |
| 25 Jun 2026 | Janku Filip | Chief Medical Officer | M-Exempt | Disposed | 30,000 | $7.56 |
| 25 Jun 2026 | Champoux Jennifer | Chief Operating Officer | M-Exempt | Acquired | 2,175 | $3.98 |
| 25 Jun 2026 | Champoux Jennifer | Chief Operating Officer | S-Sale | Disposed | 2,175 | $20.00 |
| 25 Jun 2026 | Champoux Jennifer | Chief Operating Officer | M-Exempt | Disposed | 2,175 | $3.98 |
| 25 Jun 2026 | Townson Sharon | Chief Scientific Officer | M-Exempt | Acquired | 3,000 | $6.14 |